A study of 11,000 cancer patients reveals 42 hereditary genes which predispose individuals to a higher number of mutations that correlate with a greater probability of developing cancer.
The research may lead to new personalized prevention and/or early detection strategies that assess a patient’s hereditary risk of developing different types of cancer.
The study is the result of a collaboration between the Institute for Research in Biomedicine and the Centre for Genomic Regulation. It is published today in the journal Nature Communications.
